Skip to content

Visual Perception After Virtual Implantation

Evaluation of Visual Perception Through Diffractive Optical Lens Designs by Virtual Implantation.

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT04967612
Enrollment
74
Registered
2021-07-19
Start date
2021-05-10
Completion date
2021-08-19
Last updated
2021-10-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Healthy

Brief summary

Evaluation of visual perception through diffractive optical lens designs by virtual implantation.

Interventions

OTHERVirtual implantation

Temporary placement of virtual optical lens in the crystalline lens plane.

Sponsors

Carl Zeiss Meditec AG
Lead SponsorINDUSTRY

Study design

Allocation
RANDOMIZED
Intervention model
CROSSOVER
Primary purpose
BASIC_SCIENCE
Masking
TRIPLE (Subject, Investigator, Outcomes Assessor)

Eligibility

Sex/Gender
ALL
Age
18 Years to 50 Years
Healthy volunteers
Yes

Inclusion criteria

* Male or female subjects between and including 18 and 50 years of age; * Healthy eyes; * Dominant eye with a monocular CDVA ≥1.0 decimal (≤ 0.0 logMAR) without cycloplegia; * Subject who has been informed of the consequences and constraints of the protocol and who has given his/her written informed consent; * Negative COVID19 screening test prior to every trial visit.

Exclusion criteria

* Subjects of less than 18 or more than 50 years of age; * Monocular CDVA of dominant eye \< 1.0 decimal (\> 0.0 logMAR) without cycloplegia; * Subject unable to comply with the study protocol or likely to be non-cooperative during the study; * Subject whose freedom is impaired by administrative or legal issues, or adult persons under legal protection or unable to give an informed consent; * Pseudophakic subjects; * Subjects, who are unable to fixate for a longer time, e.g. strabismus, nystagmus; * Pathologic miosis; * Intake of drugs affecting vision; * Participation in another biomedical study in parallel, if it affects vision or if interactions with cycloplegia exist; * Intolerance to or contraindication to cycloplegia, e.g. due to narrow angle of the anterior ocular chamber; * Hyperopes with more than +6 D refraction.

Design outcomes

Primary

MeasureTime frameDescription
Corrected distance visual acuityduring the interventionEvaluate visual acuity at distance following virtual implantation of diffractive optical lens designs

Countries

Germany

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026